Successful Type B RDEP Meeting confirms FDA alignment on pivotal Phase 3 study design FDA indicates Opus Genetics may submit a BLA based on 6-month efficacy data, with 12-month du ...
Coming up on the San Diego Patch calendar: Kids | Sewing: Junior Designer's Nature Makers, 7-12yrs ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果